免疫检查点抑制剂心肌炎中致病性心脏巨噬细胞的扩增
该研究利用小鼠ICI心肌炎模型(Ctla4+/-Pdcd1-/-)通过单细胞RNA测序等方法探索心脏免疫景观,发现CCR2+单核细胞来源的巨噬细胞和CD8+ T细胞显著增加,其中高表达Cxcl9、Cxcl10、Gbp2b和Fcgr4的炎症性巨噬细胞亚群扩增,且ICI心肌炎患者中存在类似的表达CXCL9、CXCL10和CD16α的巨噬细胞群。消耗CD8+ T细胞或巨噬细胞以及阻断IFN-γ信号可减弱心脏中Cxcl9+Cxcl10+巨噬细胞的扩增并减轻心肌炎,提示IFN-γ阻断可能作为治疗选择。
要点
- ICI心肌炎小鼠模型中心脏CCR2+单核细胞来源巨噬细胞和CD8+ T细胞显著增加。
- 高表达Cxcl9/Cxcl10的炎症性巨噬细胞亚群在模型和患者中均扩增。
- 阻断IFN-γ信号可减少致病性巨噬细胞扩增并减轻心肌炎。
核心结论
- ICI心肌炎与IFN-γ诱导的特定炎症性巨噬细胞群体扩增相关,提示IFN-γ阻断可能作为治疗选择。
研究设计与样本
- 采用已建立的鼠ICI心肌炎模型(Ctla4+/-Pdcd1-/-),结合单细胞RNA测序、免疫染色、流式细胞术、原位RNA杂交、分子成像和抗体中和研究探索心脏免疫景观。
主要发现
- 模型心脏中CCR2+单核细胞来源巨噬细胞和CD8+ T细胞显著增加。
- 巨噬细胞区室异质,富集高表达Cxcl9、Cxcl10、Gbp2b和Fcgr4的炎症性CCR2+亚群,起源于CCR2+单核细胞。
- ICI心肌炎患者中扩增了表达CXCL9、CXCL10和CD16α(小鼠FcgR4的人类同源物)的类似巨噬细胞群体。
- 计算机预测提示T细胞与Cxcl9+Cxcl10+巨噬细胞通过IFN-γ和CXCR3信号通路相互作用。
- 消耗CD8+ T细胞或巨噬细胞以及阻断IFN-γ信号可减弱心脏中Cxcl9+Cxcl10+巨噬细胞的扩增并减轻心肌炎。
临床怎么用
- 临床需关注ICI心肌炎中IFN-γ驱动的巨噬细胞扩增,IFN-γ阻断可能成为潜在治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune checkpoint inhibitors (ICIs), antibodies targeting PD-1 (programmed cell death protein 1)/PD-L1 (programmed death-ligand 1) or CTLA4 (cytotoxic T-lymphocyte-associated protein 4), have revolutionized cancer management but are associated with devastating immune-related adverse events including myocarditis. The main risk factor for ICI myocarditis is the use of combination PD-1 and CTLA4 inhibition. ICI myocarditis is often fulminant and is pathologically characterized by myocardial infiltration of T lymphocytes and macrophages. Although much has been learned about the role of T-cells in ICI myocarditis, little is understood about the identity, transcriptional diversity, and functions of infiltrating macrophages. METHODS: We used an established murine ICI myocarditis model (Ctla4+/-Pdcd1-/- mice) to explore the cardiac immune landscape using single-cell RNA-sequencing, immunostaining, flow cytometry, in situ RNA hybridization, molecular imaging, and antibody neutralization studies. RESULTS: We observed marked increases in CCR2 (C-C chemokine receptor type 2)+ monocyte-derived macrophages and CD8+ T-cells in this model. The macrophage compartment was heterogeneous and displayed marked enrichment in an inflammatory CCR2+ subpopulation highly expressing Cxcl9 (chemokine [C-X-C motif] ligand 9), Cxcl10 (chemokine [C-X-C motif] ligand 10), Gbp2b (interferon-induced guanylate-binding protein 2b), and Fcgr4 (Fc receptor, IgG, low affinity IV) that originated from CCR2+ monocytes. It is important that a similar macrophage population expressing CXCL9, CXCL10, and CD16α (human homologue of mouse FcgR4) was expanded in patients with ICI myocarditis. In silico prediction of cell-cell communication suggested interactions between T-cells and Cxcl9+Cxcl10+ macrophages via IFN-γ (interferon gamma) and CXCR3 (CXC chemokine receptor 3) signaling pathways. Depleting CD8+ T-cells or macrophages and blockade of IFN-γ signaling blunted the expansion of Cxcl9+Cxcl10+ macrophages in the heart and attenuated myocarditis, suggesting that this interaction was necessary for disease pathogenesis. CONCLUSIONS: These data demonstrate that ICI myocarditis is associated with the expansion of a specific population of IFN-γ-induced inflammatory macrophages and suggest the possibility that IFN-γ blockade may be considered as a treatment option for this devastating condition.
引用
- Ma P, Liu J, Qin J, et al. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis. Circulation. 2023. PMID: 37746718. doi:10.1161/CIRCULATIONAHA.122.062551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。